"The new Heartsmart program at the CHI St. Vincent Heart Institute offers a series of heart screenings to ensure your heart health is where it needs to be – and it only takes about 30 minutes to complete. To request an appointment for your Heartsmart screening or learn more about the program, click the link."

During the past decade, Cardiology and Medicine Clinic conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 5 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cardiology and Medicine Clinic" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Akebia Therapeutics" with 1 trials sponsored, "Biofourmis Inc." with 1 trials sponsored, "Duke University" with 1 trials sponsored and "Gilead Sciences" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cardiology and Medicine Clinic" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Cyclerion Therapeutics" with 1 trials as a collaborator, "Regeneron Pharmaceuticals" with 1 trials as a collaborator and "Sanofi" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Cardiology and Medicine Clinic" are "Hypertension" (3 trials), "Angina Pectoris" (2 trials), "Diabetes Mellitus, Type 2" (2 trials), "Stroke" (2 trials) and "Angina" (1 trials). Many other conditions were trialed in "Cardiology and Medicine Clinic" in a lesser frequency.

Most popular intervention types in "Cardiology and Medicine Clinic" are "Drug" (7 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "BiDil" (1 trials), "BiovitalsHF" (1 trials), "Empagliflozin high dose" (1 trials) and "Empagliflozin low dose" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cardiology and Medicine Clinic" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Cardiology and Medicine Clinic". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Cardiology and Medicine Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cardiology and Medicine Clinic, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".